SHILPAMEDPharmaceuticals
Shilpa Medicare Ltd — PE Ratio & Valuation Analysis
₹348.90
+0.75%
Current P/E44.03xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E100.1x56.0% below avg
⚠️
38.6% Premium to Industry
SHILPAMED P/E 44.03x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹8.04 | ₹321 | 39.9x |
| 2024 | ₹3.67 | ₹816 | 222.2x |
| 2022 | ₹7.26 | ₹278 | 38.3x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Shilpa Medicare Ltd Valuation
Shilpa Medicare Ltd (SHILPAMED) currently trades at 44.03x earnings. The Pharmaceuticals sector average PE is 31.77x. SHILPAMED commands a premium, reflecting high growth expectations. Historically, SHILPAMED has traded at an average PE of 100.1x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
4.21%
Dividend Yield
0.14%
More on Shilpa Medicare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.